Amino Acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
about
Renal replacement therapy in acute kidney injury: controversy and consensusDosing of renal replacement therapy in acute kidney injuryAcute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).Amino acid composition in parenteral nutrition: what is the evidence?Dynamic changes in amino acid concentration profiles in patients with sepsisSustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients.Enteral nutrition formulas: which formula is right for your adult patient?Renal Medulla is More Sensitive to Cisplatin than Cortex Revealed by Untargeted Mass Spectrometry-Based Metabolomics in RatsThe implications and management of septic acute kidney injury.Nutrition support in acute kidney injury.Review of the mechanism and nutrition recommendations for patients undergoing continuous renal replacement therapy.Clinical approach to the patient with AKI and sepsis.Summary Points and Consensus Recommendations From the International Protein Summit.Protein Requirements for Critically Ill Patients With Renal and Liver Failure.Specific nutritional problems in acute kidney injury, treated with non-dialysis and dialytic modalities.An Institutional Change in Continuous Renal Replacement Therapy.
P2860
Q26998864-749456E7-DA40-41C9-B153-B5E79CA0A314Q27014704-3097A150-94B7-45E6-896C-C9F919B76FD4Q30234560-D0A56C77-A938-4A97-9F6A-25E667880602Q33753500-6EF8E3FD-493F-4EEE-9EFE-B5750F98125CQ34767773-581CE081-34B4-4F6C-9C0F-77693E91652EQ35306559-D2CF8193-4EBD-4C36-A22E-249146BC6790Q37297610-D0F140FA-FC84-4758-B287-B0EC498FE0A7Q37502435-3252E0A8-3332-43B2-8963-C9D5063BB3AEQ37704672-EB62F762-356B-4ED9-B1FF-5C9AF743A79CQ37848649-20FF87B9-ED3F-4913-9B2C-7E3B801CDA31Q37903177-99632EC4-DB55-4B39-8F13-6F36177DAC9FQ37903178-5EB2DC07-43ED-483B-8AB7-D5AD27ED0DE2Q38386070-12C4549D-A968-4987-AA0C-9D5D1830D7B9Q38733537-5B336668-B352-445C-AF29-7CE50DF9DE89Q39139047-4C4AEE32-1E8E-4A0E-B213-1F162B7433E4Q40333259-2B1EFFB8-D443-475C-BFC4-8E8E50B3CF90Q48042406-58727DA9-D1DB-4688-BB70-9DD4895D7C47
P2860
Amino Acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amino Acid requirements in cri ...... ous renal replacement therapy.
@en
Amino Acid requirements in cri ...... ous renal replacement therapy.
@nl
type
label
Amino Acid requirements in cri ...... ous renal replacement therapy.
@en
Amino Acid requirements in cri ...... ous renal replacement therapy.
@nl
prefLabel
Amino Acid requirements in cri ...... ous renal replacement therapy.
@en
Amino Acid requirements in cri ...... ous renal replacement therapy.
@nl
P2860
P356
P1433
P1476
Amino Acid requirements in cri ...... uous renal replacement therapy
@en
P2093
Cesar Alaniz
Rima A Mohammad
P2860
P304
P356
10.1592/PHCO.28.5.600
P407
P577
2008-05-01T00:00:00Z